UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000020989
Receipt No. R000024230
Official scientific title of the study Comparison of the effect of 20mg Vonoprazan,30mg,Lansoprazole and 20mg Famotidine on intragastric pH: A three-way crossover study
Date of disclosure of the study information 2016/02/22
Last modified on 2018/02/14 (Ver. 6)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Comparison of the effect of 20mg Vonoprazan,30mg,Lansoprazole and 20mg Famotidine on intragastric pH: A three-way crossover study
Title of the study (Brief title) Comparison of the effect of 20mg Vonoprazan,30mg,Lansoprazole and 20mg Famotidine on intragastric pH
Region
Japan

Condition
Condition reflux esophagitis
Classification by specialty
Gastroenterology
Classification by malignancy Others
Genomic information YES

Objectives
Narrative objectives1 The ideal medication for treatment of acid related diseases should have a rapid onset of action to promote hemostasis and symptoms.
No studies have compared directly the intragastric pH of Vonoprazan that is a new class of proton pomp inhibitor (PPI), Lansoprazole and Famotidine
Basic objectives2 Pharmacodynamics
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes intragastric pH by pH meter attached to the antimony pH electrode for 6 hour after administration
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 3
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Vonoprazan20mg-(washout period)-Lansoprazole30mg-(washout period)-Famotidine20mg
Interventions/Control_2 Lansoprazole30mg-(washout period)-Vonoprazan20mg-(washout period)-Famotidine20mg
Interventions/Control_3 Famotidine20mg-(washout period)-Lansoprazole30mg-(washout period)-Vonoprazan20mg
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male
Key inclusion criteria Patient who fills everything the following
1) Helicobacter pylori-negative male Patient
2) Patient of 20 years or more
3) Patient who gives written informed consent
Key exclusion criteria The patient who collides with either the following assumes that it doesn't put it in to the examination
1) Drug allergy
2) Patient who took medicine that influences movement and function of digestive tract such as proton pump inhibitor, H2 blocker, and NSAIDs within 4 weeks
Target sample size 15

Research contact person
Name of lead principal investigator Masahiko Inamori
Organization Yokohama City University School of Medicine
Division name Department of Medical Education
Address 3-9 Fuku-ura, Kanazawa-ku, Yokohama, Japan
TEL 045-787-2626
Email inamorim@yokohama-cu.ac.jp

Public contact
Name of contact person Hiroshi Iida
Organization Yokohama City University School of Medicine
Division name Department of Medical Education
Address 3-9 Fuku-ura, Kanazawa-ku, Yokohama, Japan
TEL 045-787-2800
Homepage URL
Email hiro0905@yokohama-cu.ac.jp

Sponsor
Institute Yokohama City University School of Medicine Department of Medical Education
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 横浜市立大学医学部

Other administrative information
Date of disclosure of the study information
2016 Year 02 Month 22 Day

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 02 Month 12 Day
Anticipated trial start date
2016 Year 03 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 02 Month 12 Day
Last modified on
2018 Year 02 Month 14 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000024230